Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik A Verburg

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2020
No time like the present: time to re-think our habits in science and continuous medical education?Frederik A Verburg
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Advantages of dosimetry in 131I therapy of differentiated thyroid carcinomaFrederik A Verburg
Nuklearmedizin. Nuclear Medicine|June 25, 2015
Is thyroid surgery performed too often in Germany?Frederik A Verburg
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2017
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapyFrederik A Verburg, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2019
Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-makingLuca Giovanella, Frederik A Verburg
Nature Reviews. Endocrinology|November 12, 2016
Thyroid cancer: Redifferentiation - a 'new' option for <sup>131</sup>I-negative DTCFrederik A Verburg, Markus Luster
Nature Reviews. Urology|July 20, 2016
Imaging: PSMA PET-CT in initial prostate cancer stagingFrederik A Verburg, Andreas Pfestroff
Thyroid : Official Journal of the American Thyroid Association|May 28, 2011
Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurementLuca Giovanella, Frederik A Verburg
Nature Reviews. Endocrinology|January 20, 2018
Thyroid cancer: Balancing benefit and risk in TSH management of DTCFrederik A Verburg, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2023
Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancerFrederik A Verburg, Stijn Keereweer
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
European Journal of Nuclear Medicine and Molecular Imaging|April 26, 2020
No time like the present: time to re-think our habits in science and continuous medical education?Frederik A Verburg
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Advantages of dosimetry in 131I therapy of differentiated thyroid carcinomaFrederik A Verburg
Nuklearmedizin. Nuclear Medicine|June 25, 2015
Is thyroid surgery performed too often in Germany?Frederik A Verburg
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2017
A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapyFrederik A Verburg, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2019
Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-makingLuca Giovanella, Frederik A Verburg
Nature Reviews. Endocrinology|November 12, 2016
Thyroid cancer: Redifferentiation - a 'new' option for <sup>131</sup>I-negative DTCFrederik A Verburg, Markus Luster
Nature Reviews. Urology|July 20, 2016
Imaging: PSMA PET-CT in initial prostate cancer stagingFrederik A Verburg, Andreas Pfestroff
Thyroid : Official Journal of the American Thyroid Association|May 28, 2011
Ruling out 131I ablation in low-risk differentiated thyroid carcinoma basing on thyroglobulin measurementLuca Giovanella, Frederik A Verburg
Nature Reviews. Endocrinology|January 20, 2018
Thyroid cancer: Balancing benefit and risk in TSH management of DTCFrederik A Verburg, Markus Luster
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2023
Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancerFrederik A Verburg, Stijn Keereweer
Pageof 23